Skip to main content

Table 1 Schedule of data collection

From: Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial

Assessment or Outcome Study Period
Time Point: Pre-FM FM Pre-SP Post-SP 3 M 6 M 12 M
Screening
 Participant eligibility       
 Adult Pre-Exercise Screening System       
 Informed consent       
 Doctor’s consent       
 Medical history and current status
 Demographics       
 Concomitant research study participation
Primary Outcomes
 Moderate-to-vigorous physical activity (MVPA)   
Secondary Outcomes
 Cardiorespiratory fitness (\( \dot{\mathrm{V}}{\mathrm{O}}_{2\mathrm{peak}} \))  
 Body composition (DXA)   
 Anthropometry (BMI)   
 Strength (isometric grip strength)   
 Blood biomarkers (IL-6, IL-8, Hepcidin, TNF-α, IGF-1, IGF-2, IGFBP-3 and CRP)   
 Self-reported physical activity (Godin)   
 Sedentary behaviour and light physical activity (accelerometry)   
 Quality of life and wellbeing (EORTC QLQ C-30, SF-36 and FACT-G)   
 Cancer-related fatigue (FACIT-F)   
 Insomnia (ISI)   
 Symptom distress (BSI)   
 Depression and anxiety (DASS, PHQ-9 and GAD-7)   
 Participant:peer supporter relationship (Therapeutic Alliance)   
 Self-efficacy   
 Barriers and enablers to PA   
Tertiary Outcomes
 Semi-structured interviews       
 Physical activity preferences   
 Economic evaluation (AQoL-8D)   
 Adverse and serious adverse events  
  1. Key: Pre-FM pre-familiarisation, FM familiarisation, Pre-SP pre-supervised phase, Post-SP post-supervised phase, 3 M 3-months post-randomisation testing, 6 M 6-months post-randomisation testing, 12 M 12-months post-randomisation testing, \( \dot{\mathrm{V}}{\mathrm{O}}_{2\mathrm{peak}} \) peak volume of oxygen consumption, DXA dual energy X-ray absorptiometry, BMI body mass index, IL-6 interleukin 6, IL-8 interleukin 8, TNF-α tumour necrosis factor – alpha, IGF-1 insulin-like growth factor 1, IGF-2 insulin-like growth factor 2, IGFBP-3 insulin-like growth factor-binding protein 3, CRP C-reactive protein, Godin Godin Leisure-Time Physical Activity Questionnaire, EORTC QLQ C-30 European Organization for Research and Treatment of Cancer quality of life questionnaire for people with cancer, SF-36 Short form 36 health survey, FACT-G Functional Assessment of Cancer Therapy: General, FACIT-F The Functional Assessment of Chronic Illness Therapy: Fatigue, ISI Insomnia Severity Index, BSI Brief Symptom Inventory, DASS Depression Anxiety Stress Scale, PHQ-9 Patient Health Questionnaire-9, GAD-7 Generalised Anxiety Disorder 7-item scale, PA physical activity, AQoL-8D Assessment of Quality of Life – 8 Dimensions Multi-Attribute Utility Instrument